Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Omrix Biopharmaceuticals, Inc. (OMRI) since 2006 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Omrix Biopharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1349426.
Total stock buying since 2006: $1,500,147.
Total stock sales since 2006: $34,613,915.
Total stock option exercises since 2006: $1,904,627.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2008 | 117,990 | $1,461,137 | 113,637 | $3,895,361 | 113,637 | $744,542 |
| 2007 | 0 | $0 | 174,232 | $5,569,265 | 75,308 | $738,787 |
| 2006 | 3,000 | $39,010 | 873,933 | $25,149,289 | 42,728 | $421,298 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2008-03 | 117,990 | $1,461,137 | 0 | $0 | 0 | $0 |
| 2008-01 | 0 | $0 | 113,637 | $3,895,361 | 113,637 | $744,542 |
| 2007-12 | 0 | $0 | 9,091 | $345,458 | 9,091 | $194,001 |
| 2007-11 | 0 | $0 | 9,000 | $337,590 | 9,000 | $146,969 |
| 2007-08 | 0 | $0 | 2,750 | $81,097 | 2,750 | $33,742 |
| 2007-06 | 0 | $0 | 51,000 | $1,725,199 | 54,467 | $364,075 |
| 2007-01 | 0 | $0 | 102,391 | $3,079,921 | 0 | $0 |
| 2006-12 | 0 | $0 | 750,000 | $22,559,999 | 0 | $0 |
| 2006-11 | 0 | $0 | 42,728 | $976,334 | 42,728 | $421,298 |
| 2006-10 | 0 | $0 | 81,205 | $1,612,956 | 0 | $0 |
| 2006-05 | 2,000 | $28,770 | 0 | $0 | 0 | $0 |
| 2006-04 | 1,000 | $10,240 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-03-31 | Mashiach Nissim (President and COO) | Buy | 2,000 | 14.50 | 29,000 |
| 2008-03-26 | Romagnoli Philippe (Director) | Buy | 7,800 | 13.59 | 106,002 |
| 2008-03-26 | Rakin Kevin (Director) | Buy | 2,000 | 13.65 | 27,292 |
| 2008-03-20 | Taub Robert (Chief Executive Officer) | Buy | 26,400 | 12.10 | 319,519 |
| 2008-03-20 | Romagnoli Philippe (Director) | Buy | 8,250 | 12.02 | 99,198 |
| 2008-03-19 | Taub Robert (Chief Executive Officer) | Buy | 53,600 | 12.31 | 659,655 |
| 2008-03-19 | Romagnoli Philippe (Director) | Buy | 13,940 | 12.23 | 170,555 |
| 2008-03-18 | Droppert V. Marc (Executive Vice President) | Buy | 4,000 | 12.48 | 49,916 |
| 2008-01-04 | Burshtine Michael (Other) | Sale | 32,665 | 34.00 | 1,110,610 |
| 2008-01-04 | Burshtine Michael (Other) | Option Ex | 32,665 | 6.19 | 202,196 |
| 2008-01-03 | Burshtine Michael (Other) | Sale | 10,881 | 34.02 | 370,117 |
| 2008-01-03 | Burshtine Michael (Other) | Option Ex | 10,881 | 9.97 | 108,483 |
| 2008-01-02 | Burshtine Michael (Other) | Sale | 70,091 | 34.45 | 2,414,634 |
| 2008-01-02 | Burshtine Michael (Other) | Option Ex | 70,091 | 6.19 | 433,863 |
| 2007-12-11 | Mashiach Nissim (Senior VP, Operations) | Sale | 9,091 | 38.00 | 345,458 |
| 2007-12-11 | Mashiach Nissim (Senior VP, Operations) | Option Ex | 9,091 | 21.34 | 194,001 |
| 2007-11-08 | Prado Nanci (General Counsel) | Sale | 9,000 | 37.51 | 337,590 |
| 2007-11-08 | Prado Nanci (General Counsel) | Option Ex | 9,000 | 16.33 | 146,969 |
| 2007-08-13 | St Peter Steven (Director) | Sale | 2,750 | 29.49 | 81,097 |
| 2007-08-13 | St Peter Steven (Director) | Option Ex | 2,750 | 12.27 | 33,742 |
| 2007-06-29 | Horowitz Bernard (Director) | Option Ex | 2,750 | 12.27 | 33,742 |
| 2007-06-06 | Horowitz Bernard (Director) | Option Ex | 2,717 | 10.00 | 27,170 |
| 2007-06-05 | Horowitz Bernard (Director) | Sale | 2,000 | 34.50 | 69,000 |
| 2007-06-04 | Price Fredric D (Director) | Sale | 49,000 | 33.80 | 1,656,199 |
| 2007-06-04 | Price Fredric D (Director) | Option Ex | 49,000 | 6.19 | 303,163 |
| 2007-01-17 | Taub Robert (Pres., Chief Executive Officer) | Sale | 102,391 | 30.08 | 3,079,921 |
| 2006-12-20 | Taub Robert (Pres., Chief Executive Officer) | Sale | 682,606 | 30.08 | 20,532,788 |
| 2006-12-20 | Romagnoli Philippe (Vice President and Secretary) | Sale | 67,394 | 30.08 | 2,027,211 |
| 2006-11-09 | Mashiach Nissim (Senior VP, Operations) | Sale | 42,728 | 22.85 | 976,334 |
| 2006-11-09 | Mashiach Nissim (Senior VP, Operations) | Option Ex | 42,728 | 9.86 | 421,298 |
| 2006-10-24 | Evnin Luke (10% Owner) | Sale | 21,402 | 19.76 | 422,817 |
| 2006-10-24 | Gadicke Ansbert (10% Owner) | Sale | 15,095 | 19.76 | 298,216 |
| 2006-10-23 | Evnin Luke (10% Owner) | Sale | 30,483 | 19.95 | 608,135 |
| 2006-10-23 | Gadicke Ansbert (10% Owner) | Sale | 14,225 | 19.95 | 283,788 |
| 2006-05-16 | Horowitz Bernard (Director) | Buy | 1,000 | 14.20 | 14,200 |
| 2006-05-15 | Horowitz Bernard (Director) | Buy | 1,000 | 14.57 | 14,570 |
| 2006-04-24 | Horowitz Bernard (Director) | Buy | 1,000 | 10.24 | 10,240 |
Insider trading activities including stock purchases, stock sales, and option exercises of OMRI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Omrix Biopharmaceuticals, Inc. (symbol OMRI, CIK number 1349426) see the Securities and Exchange Commission (SEC) website.